Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
213 hedge funds and large institutions have $5.21B invested in Syneos Health, Inc. Class A Common Stock in 2018 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 82 increasing their positions, 74 reducing their positions, and 32 closing their positions.
201% more call options, than puts
Call options by funds: $10.9M | Put options by funds: $3.63M
36% more capital invested
Capital invested by funds: $3.84B → $5.21B (+$1.37B)
11% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 74
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
9% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 32
2% less funds holding
Funds holding: 218 → 213 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$42.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$34.4M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.1M |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$26.7M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$26.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$22.5M |
| 2 |
HSC
Harbor Spring Capital
New York
|
-$21.8M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$19.9M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$19.2M |
| 5 |
BAMCO Inc
New York
|
-$14.2M |
SYNH Hedge Fund Activity: Q2 2018 in Review
213 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q2 2018, worth a combined $5.21B — up 36% from $3.84B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of SYNH and 29 opened new positions — a net loss of 3 holders — while 74 trimmed existing stakes and 82 added.
The largest buyer was Goldman Sachs, adding an estimated $42.1M. The largest seller was Redmile Group, cutting an estimated $22.5M.
- 213 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q2 2018, down from 218 in Q1 2018.
- Funds reported $5.21B of Syneos Health, Inc. Class A Common Stock stock for Q2 2018, up 36% quarter-over-quarter.
- 29 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q2 2018 and 32 closed out, a net change of -3 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q2 2018 was Goldman Sachs, an estimated $42.1M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q2 2018 was Redmile Group, an estimated $22.5M sold.
Based on aggregated 13F filings for Q2 2018.